Literature DB >> 24525123

Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration.

Keisuke Shimbo1, Shigeru Miyaki2, Hiroyuki Ishitobi3, Yoshio Kato4, Tadahiko Kubo5, Shoji Shimose5, Mitsuo Ochi5.   

Abstract

MicroRNAs (miRNAs) have emerged as potential anticancer agents, but their clinical application is limited by the lack of an effective delivery system to tumors. Exosomes are small vesicles that play important roles in intercellular communication. Here, we show that synthetic miR-143 introduced into cells is released enveloped in exosomes and that the secreted exosome-formed miR-143 is transferred to osteosarcoma cells. The delivery of exosome-formed miR-143 significantly reduced the migration of osteosarcoma cells. The delivery efficiency of exosome-formed miR-143 was less than that achieved with lipofection, but the migratory potential of osteosarcoma cells was similarly inhibited after both strategies. Our results suggest that exosomes can deliver synthetic miR-143 and are a potentially efficient and functional delivery system.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Delivery system; Exosome; Osteosarcoma cells; miR-143

Mesh:

Substances:

Year:  2014        PMID: 24525123     DOI: 10.1016/j.bbrc.2014.02.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  95 in total

Review 1.  Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.

Authors:  Nazila Nouraee; Seyed Javad Mowla; George A Calin
Journal:  Genes Chromosomes Cancer       Date:  2015-03-31       Impact factor: 5.006

Review 2.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 3.  Engineering exosomes: a new direction for anticancer treatment.

Authors:  Benshuai You; Wenrong Xu; Bin Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 4.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 5.  Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.

Authors:  Dhruvitkumar S Sutaria; Mohamed Badawi; Mitch A Phelps; Thomas D Schmittgen
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

6.  Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection.

Authors:  Xijing Qian; Chen Xu; Shuo Fang; Ping Zhao; Yue Wang; Houqi Liu; Wen Yuan; Zhongtian Qi
Journal:  Stem Cells Transl Med       Date:  2016-08-05       Impact factor: 6.940

Review 7.  The emerging roles of exosomes in tumor-stroma interaction.

Authors:  Hailong Fu; Huan Yang; Xu Zhang; Wenrong Xu
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-17       Impact factor: 4.553

8.  Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Authors:  Adam Nowakowski; Katarzyna Drela; Justyna Rozycka; Miroslaw Janowski; Barbara Lukomska
Journal:  Stem Cells Dev       Date:  2016-09-07       Impact factor: 3.272

9.  Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model.

Authors:  Taisuke Furuta; Shigeru Miyaki; Hiroyuki Ishitobi; Toshihiko Ogura; Yoshio Kato; Naosuke Kamei; Kenji Miyado; Yukihito Higashi; Mitsuo Ochi
Journal:  Stem Cells Transl Med       Date:  2016-07-26       Impact factor: 6.940

Review 10.  The roles and implications of exosomes in sarcoma.

Authors:  Li Min; Jacson Shen; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.